139 related articles for article (PubMed ID: 35469354)
1. The RAPID3 questionnaire as a screening tool to reduce the number of outpatient clinic visits: a retrospective cohort study.
Wiegel J; Seppen BF; Ter Wee MM; Nurmohamed MT; Boers M; Bos WH
Clin Rheumatol; 2022 Aug; 41(8):2525-2531. PubMed ID: 35469354
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.
Singh H; Gupta V; Ray S; Kumar H; Talapatra P; Kaur M; Kumar S; Arya S; Mathur R; Ghangas N
Clin Rheumatol; 2012 Dec; 31(12):1663-9. PubMed ID: 22983768
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.
Kumar BS; Suneetha P; Mohan A; Kumar DP; Sarma KVS
Indian J Med Res; 2017 Nov; 146(Supplement):S57-S62. PubMed ID: 29578196
[TBL] [Abstract][Full Text] [Related]
4. Proposed severity and response criteria for Routine Assessment of Patient Index Data (RAPID3): results for categories of disease activity and response criteria in abatacept clinical trials.
Pincus T; Hines P; Bergman MJ; Yazici Y; Rosenblatt LC; MacLean R
J Rheumatol; 2011 Dec; 38(12):2565-71. PubMed ID: 22089467
[TBL] [Abstract][Full Text] [Related]
5. Performance of routine assessment of patient index data 3 (RAPID3) in monitoring disease activity of Chinese rheumatoid arthritis patients.
Zhang X; Xie A; Wang Y; Deng X; Geng Y; Ji L; Hao Y; Li G; Zhang Z
Int J Rheum Dis; 2018 Nov; 21(11):1940-1945. PubMed ID: 30402934
[TBL] [Abstract][Full Text] [Related]
6. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
Pincus T; Swearingen CJ; Bergman M; Yazici Y
J Rheumatol; 2008 Nov; 35(11):2136-47. PubMed ID: 18793006
[TBL] [Abstract][Full Text] [Related]
7. Evaluating patient reported outcomes in routine practice of patients with rheumatoid arthritis treated with biological disease modifying anti rheumatic drugs (b-DMARDs).
Boone NW; Teeuwisse P; van der Kuy PH; Janknegt R; Landewé RB
Springerplus; 2015; 4():462. PubMed ID: 26339563
[TBL] [Abstract][Full Text] [Related]
8. RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol.
Pincus T; Furer V; Keystone E; Yazici Y; Bergman MJ; Luijtens K
Arthritis Care Res (Hoboken); 2011 Aug; 63(8):1142-9. PubMed ID: 21485024
[TBL] [Abstract][Full Text] [Related]
9. Validation of RAPID3 using a Japanese version of Multidimensional Health Assessment Questionnaire with Japanese rheumatoid arthritis patients: characteristics of RAPID3 compared to DAS28 and CDAI.
Yokogawa N; Kaneko T; Nagai Y; Nunokawa T; Sawaki T; Shiroto K; Shimada K; Sugii S
Mod Rheumatol; 2015 Mar; 25(2):264-9. PubMed ID: 25156777
[TBL] [Abstract][Full Text] [Related]
10. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds.
Pincus T; Swearingen CJ; Bergman MJ; Colglazier CL; Kaell AT; Kunath AM; Siegel EL; Yazici Y
Arthritis Care Res (Hoboken); 2010 Feb; 62(2):181-9. PubMed ID: 20191516
[TBL] [Abstract][Full Text] [Related]
11. Performance of Routine Assessment of Patient Index Data 3 (RAPID3) for assessment of rheumatoid arthritis in clinical practice: differential agreement of RAPID3 according to disease activity categories.
Kim SK; Park SH; Bae J; Son JT; Choe JY
Rheumatol Int; 2014 Sep; 34(9):1311-8. PubMed ID: 24832679
[TBL] [Abstract][Full Text] [Related]
12. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.
Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
RMD Open; 2019; 5(2):e001050. PubMed ID: 31908842
[TBL] [Abstract][Full Text] [Related]
13. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
Castrejón I; Dougados M; Combe B; Guillemin F; Fautrel B; Pincus T
J Rheumatol; 2013 Apr; 40(4):386-93. PubMed ID: 23378463
[TBL] [Abstract][Full Text] [Related]
14. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care?
Pincus T
Bull NYU Hosp Jt Dis; 2009; 67(3):254-66. PubMed ID: 19852747
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Remotely Applied and Face-to-Face Disease Activity Scores in Saudi Arabian Patients With Rheumatoid Arthritis: A Prospective Cohort Study.
Almansouri AY; Alsofyani R; Alharbi HA; Almaqati AS; Aloqbi HS; Bakhsh L; Althubaiti A; Alzahrani Z
Cureus; 2024 Jan; 16(1):e52390. PubMed ID: 38361704
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of self-report questionnaires for assessing rheumatoid arthritis activity: a cross-sectional study of RAPID3 and RADAI5 and flare detection in 200 patients.
Bossert M; Prati C; Vidal C; Bongain S; Toussirot E; Wendling D
Joint Bone Spine; 2012 Jan; 79(1):57-62. PubMed ID: 21550283
[TBL] [Abstract][Full Text] [Related]
17. Cross-cultural and clinical validation of the MDHAQ/RAPID3 questionnaire in electronic format for a Brazilian population of patients with rheumatoid arthritis.
Lineburger IB; Brenol CV; Goularte AS; Pinheiro EP; Hirakata VN
Adv Rheumatol; 2022 Nov; 62(1):46. PubMed ID: 36419141
[TBL] [Abstract][Full Text] [Related]
18. Probability of Medication Intensifications in Rheumatoid Arthritis Patients With Low Disease Activity Scores on Their Patient-Reported Outcomes: A Medical-Records Review Study.
Seppen BF; Verkleij SJ; Wiegel J; Ter Wee MM; Nurmohamed MT; Bos WH
J Clin Rheumatol; 2022 Dec; 28(8):397-401. PubMed ID: 35905459
[TBL] [Abstract][Full Text] [Related]
19. One-year maintenance with routine assessment of patient index data 3-based remission may inhibit radiographic progression in patients with rheumatoid arthritis treated with routine clinical therapy: A retrospective comparison of radiographic outcome and its prognostic factors between maintained remissions with patient-reported outcome index and physician-oriented disease activity indices.
Katayama K; Okubo T; Sato T; Kamiya K; Fukai R; Abe S; Ito H; Makino Y; Kamishima T
Mod Rheumatol; 2016 Nov; 26(6):817-827. PubMed ID: 26915909
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the Virtual Monitoring Clinic, a novel nurse-led service for monitoring patients with stable rheumatoid arthritis.
Chew LC; Xin X; Yang H; Thumboo J
Int J Rheum Dis; 2019 Apr; 22(4):619-625. PubMed ID: 30450812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
